Article Information
History
- May 19, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Giulia Tini1,
- Bruno Achutti Duso1,
- Federica Bellerba1,
- Federica Corso1,
- Sara Gandini1,
- Saverio Minucci1,
- Piergiuseppe Pelicci1,2 and
- Luca Mazzarella1,3,*
- 1Dept of Experimental Oncology, European Institute of Oncology IRCCS Milan
- 2Department of Hemato-Oncology, University of Milan
- 3Division of Early Drug Development for Innovative Therapies, IEO European Institute of Oncology IRCCS, Milan, Italy
- ↵*Correspondence to: Dr Luca Mazzarella, European Institute of Oncology IRCCS Department of Experimental Oncology Via Adamello 16, 20139 Milano, Italy luca.mazzarella{at}ieo.it
Posted May 19, 2020.
Semantic and geographical analysis of Covid-19 trials reveals a fragmented clinical research landscape likely to impair informativeness
